| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung
|
Alexander, Matthew P.
|
|
2018
|
67 |
11 |
p. 1731-1742
|
artikel
|
| 2 |
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer
|
Wahba, John
|
|
2018
|
67 |
11 |
p. 1753-1765
|
artikel
|
| 3 |
Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients
|
Lin, Kai-Rong
|
|
2018
|
67 |
11 |
p. 1743-1752
|
artikel
|
| 4 |
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity
|
Neumann, Frank
|
|
2018
|
67 |
11 |
p. 1709-1718
|
artikel
|
| 5 |
Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors
|
Xie, Shan
|
|
2018
|
67 |
11 |
p. 1685-1694
|
artikel
|
| 6 |
IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells
|
Plaumann, Julian
|
|
2018
|
67 |
11 |
p. 1695-1707
|
artikel
|
| 7 |
Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients
|
Kato, Ryo
|
|
2018
|
67 |
11 |
p. 1673-1683
|
artikel
|
| 8 |
International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain
|
Berraondo, Pedro
|
|
2018
|
67 |
11 |
p. 1809-1813
|
artikel
|
| 9 |
Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands
|
Raaijmakers, Tonke K.
|
|
2018
|
67 |
11 |
p. 1789-1796
|
artikel
|
| 10 |
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
|
Yao, Yu
|
|
2018
|
67 |
11 |
p. 1777-1788
|
artikel
|
| 11 |
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities
|
Weber, Alexander N. R.
|
|
2018
|
67 |
11 |
p. 1797-1807
|
artikel
|
| 12 |
PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois
|
Haeryfar, S. M. Mansour
|
|
2018
|
67 |
11 |
p. 1669-1672
|
artikel
|
| 13 |
PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois
|
Haeryfar, S. M. Mansour
|
|
|
67 |
11 |
p. 1669-1672
|
artikel
|
| 14 |
T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient
|
Wieland, Andreas
|
|
2018
|
67 |
11 |
p. 1767-1776
|
artikel
|
| 15 |
TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma
|
Jin, Ya-bin
|
|
2018
|
67 |
11 |
p. 1719-1730
|
artikel
|
| 16 |
TIGIT: a novel immunotherapy target moving from bench to bedside
|
Solomon, Benjamin L.
|
|
2018
|
67 |
11 |
p. 1659-1667
|
artikel
|
Tijdschrift beschrijving